The Center for Regenerative Nanomedicine fosters bold new research in regenerative medicine using nanotechnology strategies. Learn More

Spotlight

VEGF-based Nanoparticles as a Therapy for Spinocerebellar Ataxia Type 1 (SCA1)

Motivated and inspired by current nanotechnology, Puneet Opal’s group will investigate the potential of using a synthetic VEGF peptide amphiphile (VEGF-PA) nano-peptide as an innovative and inexpensive alternative to recombinant VEGF for long-term therapy for cerebellar degenerations, such as Parkinson disease, Alzheimer disease, and motor neuron disorders.
Read More

CRN catalyzes new research in regenerative medicine using nanotechnology strategies.